Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in Mexico.

Denisse Añorve Bailon Francisco Javier Picó-GuzmánSergio CifuentesRogelio TrejoJerónimo Rafael Rodríguez-Cid Juan José Juárez Vignon-WhaleyAlan Alexis Heredia ZepedaRaquel GersonChristian Patricio Camacho-LimasJosé Fabián Martínez-Herrera Diana Bonilla Molina Efraín Camarín Sánchez Daniela Shveid Gerson

Published in: PharmacoEconomics - open (2024)

This study highlights the substantial clinical, economic, and social burdens of stage IV NSCLC in Mexico, revealing significant disparities between public and private healthcare sectors. It underscores the urgent need for standardized practices and equitable care across all systems.

Keyphrases

healthcare
mental health
small cell lung cancer
primary care
affordable care act
emergency department
quality improvement
health information
brain metastases
social media
chronic pain